Bluetongue virus: Virology, pathogenesis and immunity

Veterinary Research

Volumn 39, Issue 5, 2008, Pages

  Schwartz Cornil, Isabelle ^a   Mertens, Peter P C ^b   Contreras, Vanessa ^a   Hemati, Behzad ^a   Pascale, Florentina ^a   Bréard, Emmanuel ^c   Mellor, Philip S ^b   James MacLachlan, N ^d   Zientara, Stéphan ^c  

^a INRA Institut National de la Recherche Agronomique   (France)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^c ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arbovirus; Bluetongue; Orbivirus; Ruminants; Viral haemorrhagic disease

Indexed keywords

CORE PROTEIN; CYCLOOXYGENASE 2; CYTOKINE; INACTIVATED VACCINE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LIVE VACCINE; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 3; PROSTANOID; PROTEIN VP1; PROTEIN VP2; PROTEIN VP4; PROTEIN VP5; PROTEIN VP6; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ; VIRUS VACCINE; VIRUS VECTOR;

BLUETONGUE ORBIVIRUS; CATTLE DISEASE; CELL DEATH; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; EPIDEMIOLOGY; HELPER CELL; HOST; HUMORAL IMMUNITY; LIFE CYCLE; NONHUMAN; REVIEW; SHEEP DISEASE; VACCINATION; VIROGENESIS; VIROLOGY; VIRUS HEMORRHAGIC FEVER; VIRUS IMMUNITY; VIRUS LIKE AGENT; VIRUS MORPHOLOGY; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; ANIMAL; ARTICLE; CLASSIFICATION; IMMUNOLOGY; PATHOGENICITY; SHEEP;

ANIMALIA; ARBOVIRUS; BLUETONGUE VIRUS; BOVINAE; CERATOPOGONIDAE; HEXAPODA; MAMMALIA; MIRIDAE; ORBIVIRUS; OVIS ARIES; REOVIRIDAE;

ANIMALS; BLUETONGUE; BLUETONGUE VIRUS; SHEEP; VIRAL VACCINES;

EID: 51049087264     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1051/vetres:2008023     Document Type: Review

References (105)

1. Anderson G.A., Stott J.L., Gershwin L.J., Osburn B.I., Identification of bluetongue virus-specific immunoglobulin E in cattle, J. Gen. Virol. (1987) 68:2509-2514.
2. Andrew M., Whiteley P., Janardhana V., Lobato Z., Gould A., Coupar B., Antigen specificity of the ovine cytotoxic T lymphocyte response to bluetongue virus, Vet. Immunol. Immunopathol. (1995) 47:311-322.
3. Anonymous, Commission regulation (EC) No 1266/2007 of 26 October 2007 on implementing rules for Council Directive 2000/75/EC as regards the control, monitoring, surveillance and restrictions on movements of certain animals of susceptible species in relation to bluetongue, Official Journal of the European Union L 283, 27.10.2007, pp. 37-52.
4. Anthony S., Jones H., Darpel K.E., Elliott H., Maan S., Samuel A., et al., A duplex RT-PCR assay for detection of genome segment 7 (VP7 gene) from 24 BTV serotypes, J. Virol. Methods (2007) 141:188-197.
5. Barratt-Boyes S.M., Rossitto P.V., Stott J.L., MacLachlan N.J., Flow cytometric analysis of in vitro bluetongue virus infection of bovine blood mononuclear cells, J. Gen. Virol. (1992) 73:1953-1960.
6. Barratt-Boyes S.M., MacLachlan N.J., Dynamics of viral spread in bluetongue virus infected calves, Vet. Microbiol. (1994) 40:361-371.
7. Barratt-Boyes S.M., MacLachlan N.J., Pathogenesis of bluetongue virus infection of cattle, J. Am. Vet. Med. Assoc. (1995) 206:1322-1329.
8. Bhattacharya B., Noad R.J., Roy P., Interaction between bluetongue virus outer capsid protein VP2 and vimentin is necessary for virus egress, Virol. J. (2007) 4:7.
9. Bonneau K.R., DeMaula C.D., Mullens B.A., MacLachlan N.J., Duration of viraemia infectious to Culicoides sonorensis in bluetongue virus-infected cattle and sheep, Vet. Microbiol. (2002) 88:115-125.
10. Boone J.D., Balasuriya U.B., Karaca K., Audonnet J.C., Yao J., He L., et al., Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep, Vaccine (2007) 25:672-678.
11. Boyce M., Wehrfritz J., Noad R., Roy P., Purified recombinant bluetongue virus VP1 exhibits RNA replicase activity, J. Virol. (2004) 78:3994-4002.
12. Brewer A.W., MacLachlan N.J., The pathogenesis of bluetongue virus infection of bovine blood cells in vitro: ultrastructural characterization, Arch. Virol. (1994) 136:287-298.
13. Brodie S.J., Wilson W.C., O'Hearn P.M., Muthui D., Diem K., Pearson L.D., The effects of pharmacological and lentivirus-induced immune suppression on orbivirus pathogenesis: assessment of virus burden in blood monocytes and tissues by reverse transcriptionin situ PCR, J. Virol. (1998) 72:5599-5609.
14. Chiang E.T., Persaud-Sawin D.A., Kulkarni S., Garcia J.G., Imani F., Bluetongue virus and double-stranded RNA increase human vascular permeability: role of p38 MAPK, J. Clin. Immunol. (2006) 26:406-416.
15. Cowley J.A., Gorman B.M., Cross-neutralization of genetic reassortants of bluetongue virus serotypes 20 and 21, Vet. Microbiol. (1989) 19:37-51.
16. De Mattos C.C., de Mattos C.A., Osburn B.I., MacLachlan N.J., Evolution of the L2 gene of strains of bluetongue virus serotype 10 isolated in California, Virology (1994) 201:173-177.
17. DeMaula C.D., Bonneau K.R., MacLachlan N.J., Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies, Virus Res. (2000) 67:59-66.
18. DeMaula C.D., Jutila M.A., Wilson D.W., MacLachlan N.J., Infection kinetics, prostacyclin release and cytokine-mediated modulation of the mechanism of cell death during bluetongue virus infection of cultured ovine and bovine pulmonary artery and lung microvascular endothelial cells, J. Gen. Virol. (2001) 82:787-794.
19. DeMaula C.D., Leutenegger C.M., Bonneau K.R., MacLachlan N.J., The role of endothelial cell-derived inflammatory and vasoactive mediators in the pathogenesis of bluetongue, Virology (2002) 296:330-337.
20. Diprose J., Burroughs J.N., Sutton G., Goldsmith A., Gouet P., Malby R., et al., Translocation portals for the substrates and products of a viral transcriptase complex: the Bluetongue virus core, EMBO J. (2001) 20:7229-7239.
21. Eksteen P.A., Huismans H., Interferon induction by bluetongue virus and bluetongue virus ribonucleic acid, Onderstepoort J. Vet. Res. (1972) 39:125-131.
22. Elbers A.R., Backx A., Ekker H.M., van der Spek A.N., van Rijn P.A., Performance of clinical signs to detect bluetongue virus serotype 8 outbreaks in cattle and sheep during the 2006-epidemic in The Netherlands, Vet. Microbiol. (2008) 129:156-162.
23. Ellis J.A., Luedke A.J., Davis W.C., Wechsler S.J., Mecham J.O., Pratt D.L., Elliott J.D., T lymphocyte subset alterations following bluetongue virus infection in sheep and cattle, Vet. Immunol. Immunopathol. (1990) 24:49-67.
24. Enserink M., Animal disease. Exotic disease of farm animal tests Europe's responses, Science (2008) 319:710-711.
25. Forzan M., Wirblich C., Roy P., A capsid protein of nonenveloped bluetongue virus exhibits membrane fusion activity, Proc. Natl. Acad. Sci. USA (2004) 101:2100-2105.
26. Forzan M., Marsh M., Roy P., Bluetongue virus entry into cells, J. Virol. (2007) 81:4819-4827.
27. Foster N.M., Luedke A.J., Parsonson I.M., Walton T.E., Temporal relationships of viremia, interferon activity, and antibody responses of sheep infected with several bluetongue virus strains, Am. J. Vet. Res. (1991) 52:192-196.
28. Fulton R.W., Pearson N.J., Interferon induction in bovine and feline monolayer cultures by four bluetongue virus serotypes, Can. J. Comp. Med. (1982) 46:100-102.
29. + Th cell and protective humoral responses, Virology (2002) 302:383-392.
30. Gould A.R., Hyatt A.D., The orbivirus genus. Diversity, structure, replication and phylogenetic relationships, Comp. Immunol. Microbiol. Infect. Dis. (1994) 17:163-188.
31. Grimes J.M., Burroughs J.N., Gouet P., Diprose J.M., Malby R., Ziéntara S., et al., The atomic structure of the bluetongue virus core, Nature (1998) 395:470-478.
32. Guirakhoo F., Catalan J.A., Monath T.P., Adaptation of bluetongue virus in mosquito cells results in overexpression of NS3 proteins and release of virus particles, Arch. Virol. (1995) 140:967-974.
33. Han Z., Harty R.N., The NS3 protein of bluetongue virus exhibits viroporin-like properties, J. Biol. Chem. (2004) 279:43092-43097.
34. Hassan S.H., Wirblich C., Forzan M., Roy P., Expression and functional characterization of bluetongue virus VP5 protein: role in cellular permeabilization, J. Virol. (2001) 75:8356-8367.
35. Hassan S.S., Roy P., Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry, J. Virol. (1999) 73:9832-9842.
36. Hervas-Stubbs S., Rueda P., Lopez L., Leclerc C., Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN, J. Immunol. (2007) 178:2361-2369.
37. Horscroft N.J., Roy P., NTP binding and phosphohydrolase activity associated with purified bluetongue virus non-structural protein NS2, J. Gen. Virol. (2000) 81:1961-1965.
38. Huismans H., Bluetongue virus-induced interferon synthesis, Onderstepoort J. Vet. Res. (1969) 36:181-185.
39. Huismans H., Erasmus B.J., Identification of the serotype-specific and group-specific antigens of bluetongue virus, Onderstepoort J. Vet. Res. (1981) 48:51-58.
40. Huismans H., van der Walt N.T., Cloete M., Erasmus B.J., Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep, Virology (1987) 157:172-179.
41. Huismans H., Van Dijk A.A., Bluetongue virus structural components, Curr. Top. Microbiol. Immunol. (1990) 162:21-41.
42. Jameson P., Grossberg S.E., Production of interferon in human cell cultures by a new, potent viral inducer, Adv. Exp. Med. Biol. (1978) 110:37-53.
43. Jameson P., Schoenherr C.K., Grossberg S.E., Bluetongue virus, an exceptionally potent interferon inducer in mice, Infect. Immun. (1978) 20:321-323.
44. Janardhana V., Andrew M.E., Lobato Z.I., Coupar B.E., The ovine cytotoxic T lymphocyte responses to bluetongue virus, Res. Vet. Sci. (1999) 67:213-221.
45. Jeggo M.H., Wardley R.C., Generation of cross-reactive cytotoxic T lymphocytes following immunization of mice with various bluetongue virus types, Immunology (1982) 45:629-635.
46. Jeggo M.H., Gumm I.D., Taylor W.P., Clinical and serological response of sheep to serial challenge with different bluetongue virus types, Res. Vet. Sci. (1983) 34:205-211.
47. Jeggo M.H., Wardley R.C., Taylor W.P., Host response to bluetongue virus, In: Compans R.W., Bishop D.H.L. (Eds.), Double-stranded RNA Viruses, Elsevier, New York , USA, 1983, pp. 353-359.
48. Jeggo M.H., Wardley R.C., Taylor W.P., Role of neutralising antibody in passive immunity to bluetongue infection, Res. Vet. Sci. (1984) 36:81-86.
49. Jeggo M.H., Wardley R.C., Brownlie J., Importance of ovine cytotoxic T cells in protection against blue tongue virus infection, In: Barber T.L., Jochim M.M. (Eds.), Bluetongue and related orbiviruses, New York, Alan R. Liss, 1985, pp. 447-487.
50. Johnson D.J., Ostlund E.N., Stallknecht D.E., Goekjian V.H., Jenkins-Moore M., Harris S.C., First report of bluetongue virus serotype 1 isolated from a white-tailed deer in the United States, J. Vet. Diagn. Invest. (2006) 18:398-401.
51. Jones L.D., Chuma T., Hails R., Williams T., Roy P., The non-structural proteins of bluetongue virus are a dominant source of cytotoxic T cell peptide determinants, J. Gen. Virol. (1996) 77:997-1003.
52. Jones L.D., Williams T., Bishop D., Roy P., Baculovirus-expressed nonstructural protein NS2 of bluetongue virus induces a cytotoxic T-cell response in mice which affords partial protection, Clin. Diagn. Lab. Immunol. (1997) 4:297-301.
53. Kar A.K., Bhattacharya B., Roy P., Bluetongue virus RNA binding protein NS2 is a modulator of viral replication and assembly, BMC Mol. Biol. (2007) 8:4.
54. Katz J., Alstad D., Gustafson G., Evermann J., Diagnostic analysis of the prolonged bluetongue virus RNA presence found in the blood of naturally infected cattle and experimentally infected sheep, J. Vet. Diagn. Invest. (1994) 6:139-142.
55. Larke N., Murphy A., Wirblich C., Teoh D., Estcourt M.J., McMichael A.J., et al., Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen, J. Virol. (2005) 79:14822-14833.
56. Lobato Z.I., Coupar B.E., Gray C.P., Lunt R., Andrew M.E., Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens, Vet. Immunol. Immunopathol. (1997) 59:293-309.
57. Lunt R.A., Melville L., Hunt N., Davis S., Rootes C.L., Newberry K.M., et al., Cultured skin fibroblast cells derived from bluetongue virus-inoculated sheep and field-infected cattle are not a source of late and protracted recoverable virus, J. Gen. Virol. (2006) 87:3661-3666.
58. Maan S., Maan N.S., Samuel A.R., Rao S., Attoui H., Mertens P.P., Analysis and phylogenetic comparisons of full-length VP2 genes of the 24 bluetongue virus serotypes, J. Gen. Virol. (2007) 88:621-630.
59. MacLachlan N.J., Thompson J., Bluetongue virus-induced interferon in cattle, Am. J. Vet. Res. (1985) 46:1238-1241.
60. MacLachlan N.J., Nunamaker R.A., Katz J.B., Sawyer M.M., Akita G.Y., Osburn B.I., Tabachnick W.J., Detection of bluetongue virus in the blood of inoculated calves: comparison of virus isolation, PCR assay, and in vitro feeding of Culicoides variipennis, Arch. Virol. (1994) 136:1-8.
61. Mellor P.S., The replication of bluetongue virus in Culicoides vectors, Curr. Top. Microbiol. Immunol. (1990) 162:143-161.
62. Mellor P.S., Boorman J., The transmission and geographical spread of African horse sickness and bluetongue viruses, Ann. Trop. Med. Parasitol. (1995) 89:1-15.
63. Mellor P.S., Wittmann E.J., Bluetongue virus in the Mediterranean Basin 1998-2001, Vet. J. (2002) 164:20-37.
64. Mertens P.P., Sangar D.V., Analysis of the terminal sequences of the genome segments of four orbiviruses, Virology (1985) 140:55-67.
65. Mertens P.P., Burroughs J.N., Anderson J., Purification and properties of virus particles, infectious subviral particles, and cores of bluetongue virus serotypes 1 and 4, Virology (1987) 157:375-386.
66. Mertens P.P., Pedley S., Cowley J., Burroughs J.N., Corteyn A.H., Jeggo M.H., et al., Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype, Virology (1989) 170:561-565.
67. Mertens P.P., Burroughs J.N., Walton A., Wellby M.P., Fu H., O'Hara R.S., et al., Enhanced infectivity of modified bluetongue virus particles for two insect cell lines and for two Culicoides vector species, Virology (1996) 217:582-593.
68. Mertens P.P., Diprose J., The bluetongue virus core: a nano-scale transcription machine, Virus Res. (2004) 101:29-43.
69. Mertens P.P., Maan N.S., Prasad G., Samuel A.R., Shaw A.E., Potgieter A.C., et al., Design of primers and use of RT-PCR assays for typing European bluetongue virus isolates: differentiation of field and vaccine strains, J. Gen. Virol. (2007) 88:2811-2823.
70. Mertens P.P.C., Maan S., Samuel A., Attoui H., Orbivirus, Reoviridae, In: Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., Ball L.A. (Eds.), Virus taxonomy, VIIIth report of the ICTV, Elsevier/Academic press, London, UK, 2004, pp. 466-483.
71. Meyrick B., Hoover R., Jones M.R., Berry L.C. Jr., Brigham K.L., In vitro effects of endotoxin on bovine and sheep lung microvascular and pulmonary artery endothelial cells, J. Cell. Physiol. (1989) 138:165-174.
72. Monath T.P., Guirakhoo F., Orbivurses and Coltiviruses, In: Fields B.N., Knipe D.M., Howley P.M. (Eds.), Virology, Lippincott, Raven, Boston, Massachusetts, USA, 1996, pp. 1735-1766.
73. Mortola E., Noad R., Roy P., Bluetongue virus outer capsid proteins are sufficient to trigger apoptosis in mammalian cells, J. Virol. (2004) 78:2875-2883.
74. Nason E.L., Rothagel R., Mukherjee S.K., Kar A.K., Forzan M., Prasad B.V., Roy P., Interactions between the inner and outer capsids of bluetongue virus, J. Virol. (2004) 78:8059-8067.
75. Owens R.J., Limn C., Roy P., Role of an arbovirus nonstructural protein in cellular pathogenesis and virus release, J. Virol. (2004) 78:6649-6656.
76. Parsonson I., Overview of bluetongue virus infection in sheep, In: Walton T., Osburn B. (Eds.), Bluetongue, African horsesickness, and related orbiviruses, CRC Press, Boca Raton, FL, USA, 1992, pp. 713-724.
77. Parsonson I.M., Pathology and pathogenesis of bluetongue infections, Curr. Top. Microbiol. Immunol. (1990) 162:119-141.
78. Perrin A., Albina E., Bréard E., Sailleau C., Promé S., Grillet C., et al., Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants, Vaccine (2007) 25:6774-6783.
79. Purse B.V., Mellor P.S., Rogers D.J., Samuel A.R., Mertens P.P., Baylis M., Climate change and the recent emergence of bluetongue in Europe, Nat. Rev. Microbiol. (2005) 3:171-181.
80. Rinaldo C.R. Jr., Overall J.C. Jr., Glasgow L.A., Viral replication and interferon production in fetal and adult ovine leukocytes and spleen cells, Infect. Immun. (1975) 12:1070-1077.
81. Roy P., Urakawa T., Van Dijk A.A., Erasmus B.J., Recombinant virus vaccine for bluetongue disease in sheep, J. Virol. (1990) 64:1998-2003.
82. Roy P., Bluetongue virus proteins, J. Gen. Virol. (1992) 73:3051-3064.
83. Roy P., French T., Erasmus B.J., Protective efficacy of virus-like particles for bluetongue disease, Vaccine (1992) 10:28-32.
84. Roy P., Bishop D.H., LeBlois H., Erasmus B.J., Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection, Vaccine (1994) 12:805-811.
85. Saegerman C., Berkvens D., Mellor P.S., Bluetongue Epidemiology in the European Union, Emerging Infect. Dis. (2008) 14:539-544.
86. Savini G., Maclachlan N.J., Sanchez-Vizcaino J.M., Zientara S., Vaccines against bluetongue in Europe, Comp. Immunol. Microbiol. Infect. Dis. (2008) 31:101-120.
87. Shad G., Wilson W.C., Mecham J.O., Evermann J.F., Bluetongue virus detection: a safer reverse-transcriptase polymerase chain reaction for prediction of viremia in sheep, J. Vet. Diagn. Invest. (1997) 9:118-124.
88. Singh K.P., Maan S., Samuel A.R., Rao S., Meyer A., Mertens P.P., Phylogenetic analysis of bluetongue virus genome segment 6 (encoding VP5) from different serotypes, Vet. Ital. (2005) 40: 479-483.
89. Stäuber N., Martinez-Costas J., Sutton G., Monastyrskaya K., Roy P., Bluetongue virus VP6 protein binds ATP and exhibits an RNA-dependent ATPase function and a helicase activity that catalyze the unwinding of double-stranded RNA substrates, J. Virol. (1997) 71:7220-7226.
90. Stott J.L., Osburn B.I., Barber T.L., Sawyer M.M., Immunological response of sheep to an experimental inactivated BTV vaccine, J. Am. Vet. Med. Assoc. (1979) 175:611-615.
91. Stuart D.I., Gouet P., Grimes J., Malby R., Diprose J., Zientara S., et al., Structural studies of orbivirus particles, Arch. Virol. Suppl. (1998) 14:235-250.
92. Sutton G., Grimes J.M., Stuart D.I., Roy P., Bluetongue virus VP4 is an RNA-capping assembly line, Nat. Struct. Mol. Biol. (2007) 14:449-451.
93. Tabachnick W.J., Culicoides variipennis and bluetongue-virus epidemiology in the United States, Annu. Rev. Entomol. (1996) 41:23-43.
94. Takamatsu H., Jeggo M.H., Cultivation of bluetongue virus-specific ovine T cells and their cross-reactivity with different serotype viruses, Immunology (1989) 66:258-263.
95. Takamatsu H., Burroughs J.N., Wade-Evans A.M., Mertens P.P., Analysis of bluetongue virus serotype-specific and cross reactive ovine T-cell determinants in virus structural proteins, In: Walton T.E., Osburn B.I. (Eds.), Bluetongue, African horse sickness and related orbiviruses, CRC Press, Boca Raton, FL, USA, 1992, pp. 491-497.
96. Takamatsu H., Mellor P.S., Mertens P.P., Kirkham P.A., Burroughs J.N., Parkhouse R.M., A possible overwintering mechanism for bluetongue virus in the absence of the insect vector, J. Gen. Virol. (2003) 84:227-235.
97. Tan B.H., Nason E., Staeuber N., Jiang W., Monastryrskaya K., Roy P., RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells, J. Virol. (2001) 75:3937-3947.
98. Veronesi E., Hamblin C., Mellor P.S., Live attenuated bluetongue vaccine viruses in Dorset Poll sheep, before and after passage in vector midges (Diptera: Ceratopogonidae), Vaccine (2005) 23:5509-5516.
99. Wade-Evans A.M., Romero C.H., Mellor P., Takamatsu H., Anderson J., Thevasagayam J., et al., Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge, Virology (1996) 220:227-231.
100. Whetter L.E., Maclachlan N.J., Gebhard D.H., Heidner H.W., Moore P.F., Bluetongue virus infection of bovine monocytes, J. Gen. Virol. (1989) 70:1663-1676.
101. White D.M., Wilson W.C., Blair C.D., Beaty B.J., Studies on overwintering of bluetongue viruses in insects, J. Gen. Virol. (2005) 86:453-462.
102. Wilson D.C., Ma H.C., Venter E.H., van Djik A.A., Seal B.S., Mecham J.O., Phylogenetic relationships of bluetongue viruses based on gene S7, Virus Res. (2000) 67:141-151.
103. Wilson W.C., Bernard K.A., Israel B.A., Mecham J.O., Bluetongue virus serotype 17 sequence variation associated with neutralization, DNA Seq. (2008) 237-240.
104. Wirblich C., Bhattacharya B., Roy P., Nonstructural protein 3 of bluetongue virus assists virus release by recruiting ESCRT-I protein Tsg101, J. Virol. (2006) 80:460-473.
105. Zhao Y., Thomas C., Bremer C., Roy P., Deletion and mutational analyses of bluetongue virus NS2 protein indicate that the amino but not the carboxy terminus of the protein is critical for RNA-protein interactions, J. Virol. (1994) 68:2179-2185.